OncoLink Cancer Treatment and Resources

Tuesday, October 18, 2005, including Mini-Plenary Sessions

OncoLink at ASTRO 2005
OncoLink coverage of the Annual Meeting of the American Society for Therapeutic Radiology And Oncology, ASTRO, October 16-20, 2005, held in Denver, Colorado. OncoLink reporters provide in-depth, up-to-the-minute coverage of sessions and presentations.
OncoLink at ASTRO 2005
The Denver Convention Center

A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas
Presenter: T.W. FlanneryPresenter's Affiliation: Radiation Oncology, University of Maryland, Baltimore, MDType of Session: ScientificBackground One of the many recent advances in the management of high grade gliomas includes the slight survival...
Adaptive Planning and Delivery to Account for Anatomical Changes Induced by Radiation Therapy of Head and Neck Cancer
Presenter: M.B. SharpePresenter's Affiliation: Princess Margaret Hospital, Toronto, ONType of Session: PlenaryBackground Radiation-induced changes manifested during treatment can theoretically increase the risk of local failure and alter predicted...
ASTRO Patient Summary: A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas
A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas There are limited therapies available for patients with high-grade gliomas. One particular problem is finding...
ASTRO Patient Summary: Concurrent Trastuzumab and Radiation Therapy (RT) in the Adjuvant Treatment of Breast Cancer
Concurrent Trastuzumab and Radiation Therapy (RT) in the Adjuvant Treatment of Breast Cancer Patients with Her2/neu positive breast cancer are considered to have higher risk disease, but have an additional therapy option in trastuzumab (Herceptin)....
ASTRO Patient Summary: Long-Term Outcomes of RTOG 90-03: A Comparison of Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinoma
Long-Term Outcomes of RTOG 90-03: A Comparison of Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinoma Traditionally, radiation has been administered once a...
ASTRO Patient Summary: Long-Term Results of a Prospective Trial of Mantle Irradiation (RT) Alone for Early-Stage Hodgkin's Disease (HD)
Long-Term Results of a Prospective Trial of Mantle Irradiation (RT) Alone for Early-Stage Hodgkin's Disease (HD) Historically, patients with early stage Hodgkin's Disease were treated with radiation therapy alone. More recently, chemotherapy has...
ASTRO Patient Summary: Objective Versus Subjective Assessment of Single Photon Emission Computed Tomography (SPECT) Cardiac Perfusion Scans to Assess for Radiation Therapy (RT) Induced Cardiac Injury
Objective Versus Subjective Assessment of Single Photon Emission Computed Tomography (SPECT) Cardiac Perfusion Scans to Assess for Radiation Therapy (RT) Induced Cardiac Injury It has long been known that women who receive radiation to the left...
ASTRO Patient Summary: Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy
Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy Patients who present with locally advanced breast cancer (spread to local lymph...
ASTRO Patient Summary: The Influence of Intrafraction Movement on Margins for Prostate Radiotherapy
The Influence of Intrafraction Movement on Margins for Prostate Radiotherapy When a patient is set up for radiation treatment, the physician applies pinpoint skin marks called "tattoos" to guide the x-ray beams each day and to assure that the...
Concurrent Trastuzumab and Radiation Therapy (RT) in the Adjuvant Treatment of Breast Cancer
Presenter: J. R. BellonPresenter's Affiliation: Dana-Farber Cancer InstituteType of Session: ScientificBackground Her-2-Neu is overexpressed in approximately 25% of breast cancer patients and confers a worse prognosis. Adjuvant trastuzumab improves...
Dose-Dependent Effects of Radiation Therapy on Cerebral Blood Flow, Metabolism and Neurocognitive Dysfunction
Presenter: C.A. HahnPresenter's Affiliation: Radiation Oncology, Duke University Medical Center, Durham, NCType of Session: ScientificBackground Radiation therapy can cause neurocognitive dysfunction in patients treated for brain tumors. ...
Dosimetric Correlation of Acute and Late Xerostomia with Patients Treated with IMRT and Chemotherapy
Presenter: A.K. BhatnagarPresenter's Affiliation: Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PAType of Session: ScientificBackground One of the greatest determinants of quality of life following radiation for head and...
Lobular Carcinoma in Situ (LCIS) in Association with Invasive Breast Cancer: Does LCIS Predict for Local Recurrence?
Presenter: S. JollyPresenter's Affiliation: Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, Pathology, William Beaumont Hospital, Royal Oak, MIType of Session: ScientificBackground More than 5% of malignant breast cancers have a...
Long-Term Outcomes of RTOG 90-03: A Comparison of Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinoma
Presenter: A. TrottiPresenter's Affiliation: Moffitt Cancer Center at Univ. South Florida, Tampa, FLType of Session: ScientificBackground In the late 1980's, a variety of radiation dose fractionation schedules were in use at different...
Long-Term Results of a Prospective Trial of Mantle Irradiation (RT) Alone for Early-Stage Hodgkin's Disease (HD)
Presenter: Andrea NgPresenter's Affiliation: Brigham and Women's Hospital, Boston, MAType of Session: ScientificBackground The historical approach to the management of early stage Hodgkin's disease was radiation alone. Recently, the...
Objective Versus Subjective Assessment of Single Photon Emission Computed Tomography (SPECT) Cardiac Perfusion Scans to Assess for Radiation Therapy (RT) Induced Cardiac Injury
Presenter: Robert G. Prosnitz, MDPresenter's Affiliation: Duke University Medical Center, Durham, NCType of Session: PlenaryBackground Radiation therapy has been used in the treatment of breast cancer for many years. Multiple clinical...
Radiation is an Important Component of Therapy for Patients with Stage III Breast Cancer Who Achieve a Pathological Complete Response after Neoadjuvant Chemotherapy
Presenter: SE McGuirePresenter's Affiliation: Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TXType of Session: ScientificBackground Neoadjuvant chemotherapy is the standard for locally advanced breast cancer and for...
The Association Between the Mean Heart Dose, Mean Lung Dose, Tumor Location and RT-associated Heart and Lung Toxicity
Presenter: L.B. MarksPresenter's Affiliation: Radiation Oncology, Duke University Medical Center, Durham, NCType of Session: ScientificBackground One of the side effects of lung irradiation is radiation pneumonitis, which can be manifested as...
The Influence of Intrafraction Movement on Margins for Prostate Radiotherapy
Presenter: D. W. LitzenbergPresenter's Affiliation: University of MichiganType of Session: PlenaryBackground As set-up and interfraction errors are being reduced by in-room imaging guidance, the importance of intrafraction errors increases....
Volume of Abnormal Tumor Tissue on FDG-PET -A Predictor of Progression-free Survival in Hodgkin's Lymphoma?
Presenter: Martin HutchingsPresenter's Affiliation: Copenhagen University Hosptial, Copenhagen, DenmarkType of Session: ScientificBackground Pre-treatment tumor volume is a well characterized independent risk factor for developing tumor...
OncoLink I wish u knew...

As an oncologist, Dr. Giantonio provides care for many patients at the end of life, which he describes as a privilege and rewarding. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS